Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
September 18, 2023 08:57 ET
|
Harvard Bioscience, Inc.; Etisense
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical...
Harvard Bioscience Announces Second Quarter 2023 Financial Results
August 08, 2023 07:18 ET
|
Harvard Bioscience, Inc.
Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass.,...
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
August 03, 2023 18:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the...
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
July 27, 2023 18:36 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August...
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
June 22, 2023 07:55 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 3000 Indexes,...
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
June 20, 2023 08:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer...
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
May 02, 2023 17:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces First Quarter 2023 Financial Results
April 25, 2023 08:01 ET
|
Harvard Bioscience, Inc.
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4...
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
April 18, 2023 17:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral...
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
April 17, 2023 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April...